Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies
US9169255B2 · kind B2 · utility
2Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2012 |
| Grant date | Oct 27, 2015 |
| Priority date | — |
| Expiry date | Oct 10, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and their pharmaceutically acceptable salts for treatment of β-amyloid diseases, such as observed in Alzheimer's disease and synucleinopathies, such as Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.